Vivasure Medical ceases channel updates following Haemonetics acquisition
The company directs followers to Haemonetics Interventional Technologies and Haemonetics for company news, product updates and announcements.
See the latest news and media coverage for Vivasure Medical. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical device company developing vascular closure systems
vivasuremedical.comLast updated
In short: Vivasure Medical was acquired by Haemonetics for €100 million upfront plus up to €85 million contingent.
The company directs followers to Haemonetics Interventional Technologies and Haemonetics for company news, product updates and announcements.
The deal includes €100 million upfront in cash and up to €85 million more in contingent consideration tied to sales growth and milestone achievements. Vivasure expects greater scale for PerQseal Elite.
The submission covers its PerQseal Elite vascular closure device, and the company also secures an expanded venous indication in Europe.
The European regulatory approval covers the company's PerQseal Elite vascular closure system.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or...
Dive Brief: Haemonetics will acquire Vivasure Medical, an Ireland-based firm that makes a patch device for percutaneous vessel closure, the companies...
European venture capital firm EQT Life Sciences said Monday that it has sold its stake in Irish biotechnology company Vivasure Medical to Haemonetics Corp., which...
Vivasure has also received FDA approval to begin a pivotal study for its synthetic PerQseal implant, which seals blood vessels from the inside. Galway medtech...
Track Vivasure Medical and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.